These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice. Lui SL; Tsang R; Wong D; Chan KW; Chan TM; Fung PC; Lai KN Lupus; 2002; 11(7):411-8. PubMed ID: 12195781 [TBL] [Abstract][Full Text] [Related]
8. Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. Gilkeson GS; Mudgett JS; Seldin MF; Ruiz P; Alexander AA; Misukonis MA; Pisetsky DS; Weinberg JB J Exp Med; 1997 Aug; 186(3):365-73. PubMed ID: 9236188 [TBL] [Abstract][Full Text] [Related]
14. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats. Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H Artery; 1998; 23(1):1-9. PubMed ID: 10846613 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice. Weinberg JB Environ Health Perspect; 1998 Oct; 106 Suppl 5(Suppl 5):1131-7. PubMed ID: 9788887 [TBL] [Abstract][Full Text] [Related]
16. Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis. Oates JC; Halushka PV; Hutchison FN; Ruiz P; Gilkeson GS Am J Med Sci; 2011 Feb; 341(2):101-5. PubMed ID: 20924284 [TBL] [Abstract][Full Text] [Related]
17. Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines. Freeman BD; Zeni F; Banks SM; Eichacker PQ; Bacher JD; Garvey EP; Tuttle JV; Jurgensen CH; Natanson C; Danner RL Crit Care Med; 1998 May; 26(5):877-86. PubMed ID: 9590318 [TBL] [Abstract][Full Text] [Related]
18. Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-beta1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice. Yang CW; Yu CC; Ko YC; Huang CC Clin Exp Immunol; 1998 Aug; 113(2):258-64. PubMed ID: 9717976 [TBL] [Abstract][Full Text] [Related]
19. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice. Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248 [TBL] [Abstract][Full Text] [Related]
20. Effects of oral administration of malathion on the course of disease in MRL-lpr mice. Rodgers KE J Autoimmun; 1997 Aug; 10(4):367-73. PubMed ID: 9237800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]